Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRHR | P34981 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | MC4R | P32245 | 1/20 | 0.49 |
| ▸ | MC3R | P41968 | 1/20 | 0.49 |
| ▸ | MC1R | Q01726 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7644944 | 0.87 | TRHR (0.71) | TRHR | |
| SCHEMBL8260031 | 0.87 | TRHR (0.55) | TRHRMC4RMC3RMC1R | |
| SCHEMBL4955742 | 0.87 | TRHR (0.71) | TRHR | |
| SCHEMBL14028675 | 0.81 | TRHR (0.53) | TRHR | |
| SCHEMBL14028661 | 0.81 | TRHR (0.78) | TRHR | |
| SCHEMBL10335229 | 0.81 | LMNA (0.54) | TRHRALDH1A1HSD17B10 | |
| SCHEMBL2791669 | 0.81 | LMNA (0.54) | TRHRALDH1A1HSD17B10 | |
| SCHEMBL15067536 | 0.81 | LMNA (0.54) | TRHRALDH1A1HSD17B10 | |
| SCHEMBL10335315 | 0.79 | GAA (0.56) | ALDH1A1HSD17B10 | |
| SCHEMBL12747827 | 0.79 | ALDH1A1 (0.71) | ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080249028-A1 | Thyrotropin-Releasing Hormone Analogs and Method of Use | ROGER WILLIAMS HOSPITAL (US) | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080249028-A1 | Thyrotropin-Releasing Hormone Analogs and Method of Use | TRHR, IAPP, TRHDE | TRHR 1/4885ALDH1A1 4763/4885HSD17B10 2023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.